The researchers analyzed thousands of electronic medical records of older adults with both diabetes and cancer and found that those who were taking GLP-1s had lower all-cause mortality than did those who were taking another type of diabetes medication, dipeptidyl peptidase 4 inhibitors (DPP-4i)
Most users inject on the same day each week, often coinciding with their testosterone injection schedule for convenience
Whether your goal is gradual, sustainable weight loss or better metabolic health during midlife, exploring semaglutide substitutes may open the door to solutions that fit your body, budget, and lifestyle
Executives, athletes, and casual dieters joined in
In this guide, you will find: The dose ranges evaluated so far (112 mg weekly) How gradual titration influences outcomes and side-effect management Key distinctions between Retatrutide and other GLP-1/GIP agonists What upcoming data may suggest about its clinical and real-world potential Key Takeaways Retatrutide is an investigational triple-agonist medication that activates GLP-1, GIP, and glucagon receptors to improve metabolism and reduce appetite
Side effects, like stomach upset, are similar to those of other weight loss drugs